These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10784438)

  • 1. Inhibition of DNA topoisomerases by nidulalin A derivatives.
    Sato S; Fukuda Y; Nakagawa R; Tsuji T; Umemura K; Andoh T
    Biol Pharm Bull; 2000 Apr; 23(4):511-2. PubMed ID: 10784438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses of novel antitumor dihydroxanthone derivatives with inhibitory activity against DNA topoisomerase II.
    Sato S; Suga Y; Yoshimura T; Nakagawa R; Tsuji T; Umemura K; Andoh T
    Bioorg Med Chem Lett; 1999 Sep; 9(18):2653-6. PubMed ID: 10509910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of topoisomerases by antitumor prostaglandins.
    Suzuki K; Shono F; Uyeda M
    Biosci Biotechnol Biochem; 1998 Oct; 62(10):2073-5. PubMed ID: 9836448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory activities of (-)-epigallocatechin-3-O-gallate against topoisomerases I and II.
    Suzuki K; Yahara S; Hashimoto F; Uyeda M
    Biol Pharm Bull; 2001 Sep; 24(9):1088-90. PubMed ID: 11558576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insight for fluoroquinophenoxazine derivatives as possibly new potent topoisomerase I inhibitor.
    Kang DH; Kim JS; Jung MJ; Lee ES; Jahng Y; Kwon Y; Na Y
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1520-4. PubMed ID: 18178085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
    Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jung MJ; Nam JM; Na Y; Cho WJ; Kwon Y; Lee ES
    Bioorg Med Chem; 2010 Mar; 18(6):2245-2254. PubMed ID: 20188578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of DNA topoisomerases II and/or I by pyrazolo[1,5-a]indole derivatives and their growth inhibitory activities.
    Umemura K; Mizushima T; Katayama H; Kiryu Y; Yamori T; Andoh T
    Mol Pharmacol; 2002 Oct; 62(4):873-80. PubMed ID: 12237334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of cytotoxicity of N-[2-(dimethylamino)ethyl] acridine-4-carboxamide and of its 7-chloro derivative: the roles of topoisomerases I and II.
    Bridewell DJ; Finlay GJ; Baguley BC
    Cancer Chemother Pharmacol; 1999; 43(4):302-8. PubMed ID: 10071981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New topoisomerases inhibitors: synthesis of rutaecarpine derivatives and their inhibitory activity against topoisomerases.
    Kim SI; Lee SH; Lee ES; Lee CS; Jahng Y
    Arch Pharm Res; 2012 May; 35(5):785-9. PubMed ID: 22644846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103.
    Etiévant C; Kruczynski A; Barret JM; Perrin D; van Hille B; Guminski Y; Hill BT
    Cancer Chemother Pharmacol; 2000; 46(2):101-13. PubMed ID: 10972479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic and DNA topoisomerases I and II inhibitory constituents from the roots of Aralia cordata.
    Seo CS; Li G; Kim CH; Lee CS; Jahng Y; Chang HW; Son JK
    Arch Pharm Res; 2007 Nov; 30(11):1404-9. PubMed ID: 18087808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some benzoxazoles and benzimidazoles as DNA topoisomerase I and II inhibitors.
    Oksuzoglu E; Tekiner-Gulbas B; Alper S; Temiz-Arpaci O; Ertan T; Yildiz I; Diril N; Sener-Aki E; Yalcin I
    J Enzyme Inhib Med Chem; 2008 Feb; 23(1):37-42. PubMed ID: 18341251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lignans from the bark of Machilus thunbergii and their DNA topoisomerases I and II inhibition and cytotoxicity.
    Li G; Lee CS; Woo MH; Lee SH; Chang HW; Son JK
    Biol Pharm Bull; 2004 Jul; 27(7):1147-50. PubMed ID: 15256759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of beta- and gamma-carboline derivatives of DNA topoisomerase activities.
    Funayama Y; Nishio K; Wakabayashi K; Nagao M; Shimoi K; Ohira T; Hasegawa S; Saijo N
    Mutat Res; 1996 Feb; 349(2):183-91. PubMed ID: 8600349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase inhibition by phenolic metabolites: a potential mechanism for benzene's clastogenic effects.
    Chen H; Eastmond DA
    Carcinogenesis; 1995 Oct; 16(10):2301-7. PubMed ID: 7586126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel selective inhibitors for human topoisomerase I, BM2419-1 and -2 derived from saintopin.
    Ishiyama D; Futamata K; Futamata M; Kasuya O; Kamo S; Yamashita F; Kanazawa S
    J Antibiot (Tokyo); 1998 Dec; 51(12):1069-74. PubMed ID: 10048564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A.
    Bielawski K; Winnicka K; Bielawska A
    Biol Pharm Bull; 2006 Jul; 29(7):1493-7. PubMed ID: 16819197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA sequence selectivity of topoisomerases and topoisomerase poisons.
    Capranico G; Binaschi M
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):185-94. PubMed ID: 9748568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of DNA topoisomerases.
    Drlica K; Franco RJ
    Biochemistry; 1988 Apr; 27(7):2253-9. PubMed ID: 2838070
    [No Abstract]   [Full Text] [Related]  

  • 20. Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes.
    Meng LH; Zhang JS; Ding J
    Biochem Pharmacol; 2001 Sep; 62(6):733-41. PubMed ID: 11551518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.